WHO ICTRP trial
Study on optimal blood transport reconstruction strategy for acute STEMI
ChiCTR1800015887 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800015887 |
|---|---|
| Public title | Study on optimal blood transport reconstruction strategy for acute STEMI |
| Scientific title | a randomized controlled trial on optimal blood transport reconstruction strategy for acute STEMI |
| Primary sponsor | Zhejiang Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | acute STEMI |
| Interventions | 1:routine PCI;2:primary PCI;3:delayed PCI |
| Registration date | Apr 26, 2018 |
| Target size | 1:120;2:120;3:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: